Fundraising Fox

Hiroki Sato

Senior Venture Partner, Investment Division / 投資部 シニアベンチャーパートナー at OSAKA University Venture Capital

About

After five pharma companies he joined OUVC in October 2022, handling technical evaluation of drug discovery and life science seeds. He spent 25 years in drug discovery research plus alliance management, licensing and clinical/epidemiology work.

Colleagues at OSAKA University Venture Capital